Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

CD34+ Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction. #SCAI2020
News
Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction

May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to ...

Home May 17, 2020
Home
Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell
News | Pharmaceuticals
Icosapent Ethyl Significantly Reduces Revascularizations in Statin Patients

May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy ...

Home May 17, 2020
Home
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020
News | Stents
TWILIGHT Trial Substudy Examines Bioabsorbable Polymer vs. Durable Polymer Drug-Eluting Stents in High-Risk PCI

May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) ...

Home May 17, 2020
Home
Cindy Grines Becomes SCAI President in 2020. #SCAI2020
News | SCAI
Cindy Grines Becomes SCAI President

May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary ...

Home May 17, 2020
Home
The protocol chart for the LATIN STEMI telecardiology program.
News | Telecardiology
Telemedicine-based Network Offers Remote Guidance to 100 Million STEMI Patients

May 15, 2020 – A groundbreaking trial recently examined the viability of telemedicine for remote guidance of a ...

Home May 15, 2020
Home
An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.
News | FFR Technologies
OCT May be Able to Show FFR Without Need for Pressurewire

May 15, 2020 – A late-breaking study aimed to evaluate whether optical coherence tomography (OCT) can predict fractional ...

Home May 15, 2020
Home
CMS now reimburses for outpatient center same-day percutenous coronary intervention but SCAI says quality guidelines need to be met. SCAI Expert Consensus Statement on Out of Hospital Cardiac Arrest. Catheterization and Cardiovascular Interventions
Feature | Cath Lab
SCAI Issues Position Statement on PCI Performance in Ambulatory Surgical Centers

May 15, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) issued a position statement on the ...

Home May 15, 2020
Home
New York City newspaper headlines from April 1, 2020, and masked police officers at a subway station in Manhattan clearly outline the issues facing the city's hospitals during the height of COVID-19 pandemic in New York. Photo by Mike Borchardt. How Cardiology Dealt With the COVID-19 Surge in New York City
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
How Cardiology Dealt With the COVID-19 Surge in New York City

Over the past three months COVID-19 has dominated nearly all healthcare news, so it is not surprising that the virus ...

Home May 14, 2020
Home
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab
PODCAST: Cath Lab Precautions Under the COVID-19 Pandemic - SCAI Guidelines

This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography ...

Home May 13, 2020
Home
​​​​​​​American College of Cardiology, ACC, NCDR Chest Pain MI and CathPCI Registries Collect COVID-19 Data
News | Coronavirus (COVID-19)
​​​​​​​American College of Cardiology Registries Collect COVID-19 Data

May 11, 2020 — The American College of Cardiology (ACC) will begin collecting COVID-19 (SARS-CoV-2) data through the Nat ...

Home May 11, 2020
Home
Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.
Feature | Coronavirus (COVID-19)
Practical Diagnosis and Treatment of Suspected Venous Thromboembolism During COVID-19 Pandemic

May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of ...

Home May 04, 2020
Home
SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations. A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.
News | Congenital Heart
SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations

May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on ...

Home May 04, 2020
Home
Abiomed Adds ECMO Cardiopulmonary Support to its Portfolio with the purchase of Breethe. The Breethe ECMO system. Abiomed invested in Breethe in mid-2019. Breethe has applied for 510(k) clearance by the Food and Drug Administration (FDA).
News | ECMO Systems
Abiomed Adds ECMO Cardiopulmonary Support to its Portfolio

May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal ...

Home May 01, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: Where Have all the STEMI Cases Gone Amid COVID-19?

Thomas Maddox, M.D., MSc, FACC, the chair of the American College of Cardiology (ACC) Science and Quality Committee ...

Home May 01, 2020
Home
LivaNova Modifies its ECMO Indications Beyond Six Hours to Address COVID-19. The FDA expanded the use indications for ECMO systems April 6 so tthey can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support.
News | Coronavirus (COVID-19)
LivaNova Modifies its ECMO Indications Beyond Six Hours to Address COVID-19

April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand ...

Home April 23, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now